Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.
The generation of an autoimmune response against islet beta-cells is central to the pathogenesis of type 1 diabetes mellitus, and this response is driven by the stimulation of autoreactive lymphocytes by components of the beta-cells themselves. Reactive oxygen species (ROS) have been implicated in the beta-cell destruction which leads to type 1 diabetes and may modify beta-cell components so as to enhance their immunogenicity. We investigated the effects of oxidation reactions catalysed by copper or iron on the major beta-cell autoantigen glutamic acid decarboxylase (GAD). Lysates of purified rat islets were exposed to copper or iron sulphate with or without hydrogen peroxide or ascorbic acid. Immunostaining showed that these treatments generated high molecular weight covalently linked aggregates containing GAD. These are not formed by intermolecular disulphide bonds between cysteine residues since they cannot be resolved into monomeric form when electrophoresed under extreme reducing conditions. There was no modification of insulin or pro-insulin by ROS. The same oxidative changes to GAD could be induced in viable islet cells treated with copper sulphate and hydrogen peroxide, and thus the modifications are not an artefact of the catalysed oxidation of cell-free lysates. Sera from patients with type 1 diabetes and stiffman syndrome containing GAD antibodies reacted predominantly with the highest molecular weight modified protein band of GAD: normal human sera did not precipitate GAD. Thus, oxidatively modified aggregates of GAD react with serum antibodies of type 1 diabetes patients and some SMS patients: this is consistent with oxidative modifications of autoantigens being relevant to the pathogenesis of type 1 diabetes.
Trigwell
S M
SM
Division of Immunology, School of Clinical Laboratory Sciences, University of Nottingham, Nottingham, UK.
Radford
P M
PM
Page
S R
SR
Loweth
A C
AC
James
R F
RF
Morgan
N G
NG
Todd
I
I
D000818:Animals; D000911:Antibodies, Monoclonal; D001205:Ascorbic Acid / Q000494:pharmacology; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000737:chemistry; D003300:Copper / Q000494:pharmacology; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000276:immunology* / Q000378:metabolism*; D005968:Glutamate Decarboxylase / Q000737:chemistry* / Q000276:immunology*; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D007501:Iron / Q000494:pharmacology; D007515:Islets of Langerhans / Q000187:drug effects / Q000201:enzymology* / Q000276:immunology*; D007527:Isoenzymes / Q000737:chemistry / Q000276:immunology; D008970:Molecular Weight; D010084:Oxidation-Reduction; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D001324:Autoantigens; D007527:Isoenzymes; D017382:Reactive Oxygen Species; C024211:islet cell antibody; D003300:Copper; D006861:Hydrogen Peroxide; D007501:Iron; D005968:Glutamate Decarboxylase; D001205:Ascorbic Acid